Overview

Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Therapeutic interventions for patients with metastatic breast cancer are aimed at prolonging survival and improving the quality of life. The objective of this trial is to assess if an initial chemotherapy followed by an endocrine therapy leads to a longer disease-free interval as compared to chemotherapy alone.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Letrozole